Aralez Bio – January 2025
Aralez Bio is a platform technology company revolutionizing the synthesis of noncanonical amino acids, ncAAs, through biocatalysis. Their proprietary processes enable the production of thousands of ncAAs sustainably at production scales. Founded in 2019 Aralez Bio has rapidly advanced in the biotech industry. In December 2024, the company secured Series A funding and in 2025 moved to a facility in Berkeley, CA, capable of ton-scale production. Aralez Bio's extensive collection of novel ncAAs provides unparalleled atomic-level control in peptide medicinal chemistry, empowering the development of next-generation therapeutics. Their commitment to sustainability and innovation positions us at the forefront of modern drug discovery and development.
Stay tuned for more exciting features, and don’t miss the chance to get your lab featured!
Please contact Lars Sahl to get involved!
Peptide Purification
In this sponsored content by Gyros Protein Technologies, learn how to remove impurities faster with less solvent consumption using catch-and-release technology.
Peptide-related impurities can significantly influence the outcome of drug research and development, for example, false-positive results, and must be removed to ensure high assay reliability.
Ultimately, such impurities must be removed entirely from active pharmaceutical ingredients to provide the highest quality clinical-grade material. This article tells you how.
What Current Members Say
“I have been a member of APS since I was a graduate student because of the benefits and opportunities it provided scientists at that stage of my career. Through the years, I have continued to be a member so I can engage with the top researchers working in peptide science from around the globe.”
Marcos Pires
Associate Professor of Chemistry
University of Virginia
The American Peptide Society has for many years been central to advancing and promoting peptide research through activities such as regular symposiums, the Peptide Science Journal, and ongoing webinars and news highlights. These efforts are an essential contribution to the field which benefits both the academic and industrial communities.
Jon Collins
Director of Business Development
CEM
"Attending the American Peptide Symposium as a PhD student allowed me to engage with research at the cutting-edge of peptide chemistry, and offered an amazing networking opportunity within a warm and inclusive community. I hope to attend for many years to come!"
Tess Lamer
Ph.D. Candidate
University of Alberta